Eva P. De Jongh

Dordrecht, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands - A nationwide study of drug usage and treatment outcomes.

Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands - A nationwide study of drug usage and treatment outcomes.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 31, 2025

Prospective Validation of Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell Lymphoma.

Prospective Validation of Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell Lymphoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 12, 2025

Predicting long-term absolute risk of lung cancer in Hodgkin lymphoma patients.

Predicting long-term absolute risk of lung cancer in Hodgkin lymphoma patients.

Journal: Journal of the National Cancer Institute

Published: September 12, 2025

Predicting long-term absolute risk of lung cancer in patients with Hodgkin lymphoma.

Predicting long-term absolute risk of lung cancer in patients with Hodgkin lymphoma.

Journal: Journal of the National Cancer Institute

Published: September 12, 2025

Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma.

Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma.

Journal: Journal of the National Cancer Institute

Published: September 08, 2025

Cell-free DNA genomic and fragmentomic features for early outcome prediction in large B cell lymphoma.

Cell-free DNA genomic and fragmentomic features for early outcome prediction in large B cell lymphoma.

Journal: Cell reports. Medicine

Published: June 30, 2025

Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/ refractory acute myeloid leukemia.

Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/ refractory acute myeloid leukemia.

Journal: Haematologica

Published: May 08, 2025

Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Long-term results of the HOVON-84 randomized phase III study by the HOVON and the Nordic Lymphoma Group (clinical trial number: NTR1014).

Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Long-term results of the HOVON-84 randomized phase III study by the HOVON and the Nordic Lymphoma Group (clinical trial number: NTR1014).

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 04, 2024

Atezolizumab consolidation in patients with high-risk diffuse large B-cell lymphoma in complete remission after R-CHOP.

Atezolizumab consolidation in patients with high-risk diffuse large B-cell lymphoma in complete remission after R-CHOP.

Journal: Blood advances

Published: November 01, 2024

Treatment-Free Remission Outcomes in a BCR::ABL1 Digital PCR Selected Clinical Cohort of CML Patients.

Treatment-Free Remission Outcomes in a BCR::ABL1 Digital PCR Selected Clinical Cohort of CML Patients.

Journal: European journal of haematology

Published: August 25, 2024

Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.

Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 15, 2024

Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma.

Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma.

Journal: ESMO open

Published: October 13, 2023

Showing 1-12 of 32

Last Updated: 09/26/2026